314 related articles for article (PubMed ID: 18179681)
1. Comparison of a novel viscous platelet additive solution and plasma: preparation and in vitro storage parameters of buffy-coat-derived platelet concentrates.
Zhang JG; Carter CJ; Devine DV; Scammell K; Weiss S; Gyongyossy-Issa MI
Vox Sang; 2008 May; 94(4):299-305. PubMed ID: 18179681
[TBL] [Abstract][Full Text] [Related]
2. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
[TBL] [Abstract][Full Text] [Related]
3. Novel system for storage of buffy-coat-derived platelet concentrates in a glucose-based platelet additive solution: parameters and metabolism during storage and comparison to plasma.
Gyongyossy-Issa MI; Zhang JG; Culibrk B; Hunter F; Levin E; Scammell K; Weiss S; Holmes DL; Holme S
Vox Sang; 2009 Aug; 97(2):102-9. PubMed ID: 19508670
[TBL] [Abstract][Full Text] [Related]
4. Platelets stored in a new-generation container differences between plasma and platelet additive solution II.
de Wildt-Eggen J; Schrijver JG; Smid WM; Joie M; Bollinne V; Bins M
Vox Sang; 1998; 75(3):218-23. PubMed ID: 9852410
[TBL] [Abstract][Full Text] [Related]
5. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over.
Sandgren P; Mayaudon V; Payrat JM; Sjödin A; Gulliksson H
Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514
[TBL] [Abstract][Full Text] [Related]
6. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.
Cardigan R; Sutherland J; Garwood M; Bashir S; Turner C; Smith K; Hancock V; Wiltshire M; Pergande C; Williamson LM
Vox Sang; 2008 Feb; 94(2):103-12. PubMed ID: 18034786
[TBL] [Abstract][Full Text] [Related]
7. Storage of platelet-rich plasma-derived platelet concentrate pools in plasma and additive solution.
Sweeney J; Kouttab N; Holme S; Kurtis J; Cheves T; Nelson E
Transfusion; 2006 May; 46(5):835-40. PubMed ID: 16686852
[TBL] [Abstract][Full Text] [Related]
8. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
Sandgren P; Hansson M; Gulliksson H; Shanwell A
Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
[TBL] [Abstract][Full Text] [Related]
9. Interruption of agitation of platelet concentrates: effects on in vitro parameters.
van der Meer PF; Gulliksson H; Aubuchon JP; Prowse C; Richter E; de Wildt-Eggen J;
Vox Sang; 2005 May; 88(4):227-34. PubMed ID: 15877643
[TBL] [Abstract][Full Text] [Related]
10. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution.
Diedrich B; Sandgren P; Jansson B; Gulliksson H; Svensson L; Shanwell A
Vox Sang; 2008 Feb; 94(2):96-102. PubMed ID: 18034788
[TBL] [Abstract][Full Text] [Related]
12. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
[TBL] [Abstract][Full Text] [Related]
13. Effect of platelet additive solution on bacterial dynamics and their influence on platelet quality in stored platelet concentrates.
Greco CA; Zhang JG; Kalab M; Yi QL; Ramirez-Arcos SM; Gyongyossy-Issa MI
Transfusion; 2010 Nov; 50(11):2344-52. PubMed ID: 20553431
[TBL] [Abstract][Full Text] [Related]
14. Automated preparation of whole blood-derived platelets suspended in two different platelet additive solutions and stored for 7 days.
Cid J; Magnano L; Molina P; Diaz-Ricart M; Martínez N; Maymó RM; Puig L; Lozano M; Escolar G; Galán AM
Transfusion; 2014 Feb; 54(2):426-33. PubMed ID: 23721299
[TBL] [Abstract][Full Text] [Related]
15. Storage of buffy coat-derived platelets in additive solutions: in vitro effects of storage at 4 degrees C.
Sandgren P; Shanwell A; Gulliksson H
Transfusion; 2006 May; 46(5):828-34. PubMed ID: 16686851
[TBL] [Abstract][Full Text] [Related]
16. In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools.
Turner CP; Sutherland J; Wadhwa M; Dilger P; Cardigan R
Vox Sang; 2005 Apr; 88(3):164-71. PubMed ID: 15787726
[TBL] [Abstract][Full Text] [Related]
17. Storage of platelets in additive solution for up to 12 days with maintenance of good in-vitro quality.
van der Meer PF; Pietersz RN; Reesink HW
Transfusion; 2004 Aug; 44(8):1204-11. PubMed ID: 15265125
[TBL] [Abstract][Full Text] [Related]
18. Extended storage of platelets in SSP platelet additive solution.
Hornsey VS; McColl K; Drummond O; McMillan L; Morrison A; Morrison L; MacGregor IR; Prowse CV
Vox Sang; 2006 Jul; 91(1):41-6. PubMed ID: 16756600
[TBL] [Abstract][Full Text] [Related]
19. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of supernatant from pooled buffy-coat platelet concentrates throughout 7-day storage.
Glenister KM; Payne KA; Sparrow RL
Transfusion; 2008 Jan; 48(1):99-107. PubMed ID: 17894789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
